EUVIMEDEUVIMED entdecken
Crossref

A generalizable strategy for crosslinkable albumin-based hydrogels and application as potential anti-tumor nanoplatform

WanWan Lv, Kai Yang, Jingwen Yu, Yiqing Wu, Mengdi Zhang, Zichuan Liu, Xixuan Wang, Jiahui Zhou, Haoran Ma, Rongyuan Yi, Hui Chu, Jian Chen iD

Journal of Biomaterials Applications · 2023

DOI: 10.1177/08853282231166489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomaterials Applications, 2023. Verfasst von WanWan Lv und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hunan University of Science and Technology, Xiangtan, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Scientific Research Fund of Hunan Provincial Education Department, Natural Science Foundation of Hunan Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Albumin-based hydrogels have emerged as promising nanoparticle systems for the effective delivery of hydrophobic anticancer drugs. Anti-cancer drugs often cause some adverse effects, such as toxicity and rapid clearance by mononuclear phagocytic systems. Herein, a new strategy of synthesizing N-hydroxysuccinimide (NHS)-activated linker to form crosslinkable albumin-based hydrogels (CABH) is reported. The CABH favored physiochemical characteristics improvement of doxorubicin (Dox) and drug release. The CABH was constructed depending on the crosslinking reaction between NHS activated glycerol and albumin. The size of CABH was approximately 200 nm examined by dynamic light scattering (DLS) and transmission electron microscopy (TEM). It was found that the particle size and size distribution of the CABH remained stable in neutral PBS for 1 week. Dox loaded CABH would be controllably released in weak acidic environment verified by in vitro release and in vitro cell imaging. The Dox loaded hydrogel results in significant killing in the case of acidic culture medium. Our work provides a crosslinking method to formulate albumin nanoplatform and improve the size, stability, drug loading capacity and controlled release, which throws light on the potential application in drug delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansHydrogelsDoxorubicinAlbuminsDrug Delivery Systems

Stichwörter der Autor:innen

AlbuminDoxorubicincrosslinkingdrug deliveryhydrogels

Substanzen

HydrogelsAntineoplastic AgentsDoxorubicinAlbumins

Autor:innen und Institutionen

  • Hunan University of Science and Technology, Xiangtan, China.
  • Hunan Cancer Hospital, Changsha, China.

ORCID-Profile: Jian Chen

Förderung

  • Scientific Research Fund of Hunan Provincial Education Department
  • Natural Science Foundation of Hunan Province, China

Zitieren

APA

Lv, W., Yang, K., Yu, J., Wu, Y., Zhang, M., Liu, Z., Wang, X., Zhou, J., Ma, H., Yi, R., Chu, H., & Chen, J. (2023). A generalizable strategy for crosslinkable albumin-based hydrogels and application as potential anti-tumor nanoplatform. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282231166489

Vancouver

Lv W, Yang K, Yu J, Wu Y, Zhang M, Liu Z, et al. A generalizable strategy for crosslinkable albumin-based hydrogels and application as potential anti-tumor nanoplatform. Journal of Biomaterials Applications. 2023. doi:10.1177/08853282231166489

BibTeX
@article{Lv2023,
  author = {Lv, WanWan and Yang, Kai and Yu, Jingwen and Wu, Yiqing and Zhang, Mengdi and Liu, Zichuan and Wang, Xixuan and Zhou, Jiahui and Ma, Haoran and Yi, Rongyuan and Chu, Hui and Chen, Jian},
  title = {A generalizable strategy for crosslinkable albumin-based hydrogels and application as potential anti-tumor nanoplatform},
  journal = {Journal of Biomaterials Applications},
  year = {2023},
  doi = {10.1177/08853282231166489}
}
Kostenlos starten →